A Win For BELLUS Health Inc.

BELLUS Health Inc. (BLU:NASDAQ) jumped higher at $14.44, representing a gain of 98.9%. On Tue, Apr 18, 2023, BLU:NASDAQ touched a New 2-Week High of $14.44. The stock appeared on our News Catalysts scanner on Tue, Apr 18, 2023 at 05:58 PM in the 'ACQUISITION' category. From Tue, Apr 04, 2023, the stock recorded 66.67% Up Days and 60.00% Green Days

About BELLUS Health Inc. (BLU:NASDAQ)

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, development of drug candidates for health solutions.